NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional ...
Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndromes (MDS), aplastic anemia (AA), or other bone marrow failure (BMF) syndromes: Interim results from ...
Depression and EGFR mutation status in stage IV non-small cell lung cancer. Background: To evaluate the prevalence of polypharmacy and the inappropriate prescribing of medications (IPM), and to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results